Venclexta (venetoclax) - Roche, AbbVie
Xospata (gilteritinib) - Astellas
Nexavar (sorafenib) - Bayer, Amgen
Rydapt (midostaurin) - Novartis
crenolanib besylate (ARO-002) - AROG
https://ash.confex.com/ash/2020/webprogram/Paper139705.html
 
Naval Daver, MD1; Jessica K. Altman, MD2; Joseph Maly, MD3; Mark Levis, MD, PhD4; Ellen Ritchie, MD 5; Mark Litzow, MD6; James K. McCloskey, MD7; Catherine C. Smith, MD8; Gary J. Schiller, MD9; Terrence Bradley, MD10,11; Ramon V. Tiu, MD12; Wan-Jen Hong, MD13; Bo Tong, PhD14; Qin Qin, MS14; Kimberley Dilley, MD, MPH14; Alexander E. Perl, MD15
 
Nov 5, 2020
 
Prev Next